| Model Number |
BA28-60/I16-40 |
| Medical Device Problem Codes |
Use of Device Problem (1670); Improper or Incorrect Procedure or Method (2017); Patient-Device Incompatibility (2682)
|
| Health Effect - Clinical Code |
Failure of Implant (1924)
|
| Date of Event |
12/20/2019
|
|
Type of Reportable Event
|
Serious Injury
|
|
Additional Manufacturer Narrative
|
|
The devices involved in this event will not be returned for evaluation and remain implanted in the patient.If additional information is obtained at a later time that is pertinent to this event, a follow-up report will then be submitted.Device iteration is afx with duraply.Devices remain implanted in patient.
|
| |
|
Event or Problem Description
|
|
The patient was initially treated for an iliac aneurysm with the afx abdominal aortic aneurysm (aaa) stent; this is an off-label initial implant as afx is intended for aaa treatment.Approximately four and a half years post initial procedure, the patient presented with type ia and ii endoleaks as detected per ct (computed tomography) at routine follow-up.The physician plans to re-intervene and surgery is scheduled for (b)(6)2020.As of date, there have been no additional patient sequelae reported.
|
| |
|
Additional Manufacturer Narrative
|
|
The manufacturing lot evaluation confirmed all devices met specifications prior to release.The device was not returned as the device remains implanted therefore no evaluation was completed.At the completion of the clinical assessment, the type ia endoleak and type ii endoleak of the both inferior mesenteric artery (ima) and lumbars are confirmed.The type ii eendoleaks are anatomy related and the type ia endoleak is user related due to the reported right common iliac artery diameter of 37mm is off label (should be 10-23mm) and the discharge summary stated the patients primary diagnosis was peripheral arterial disease and right iliac aneurysm (off label outside of treatment range).There were no procedure related harms identified.The final patient status was discharged on the first post-operative day following a secondary endovascular procedure.No additional investigation of this reported event is planned however if additional information pertinent to the incident is obtained, a follow-up report will be submitted.Endologix will continue to monitor this complaint and similar complaints in the event further investigation is needed.Device iteration is afx with duraply.Corrections: h6: result remove code 3233.H6: conclusion remove code 11.
|
| |
|
Event or Problem Description
|
|
The patient was initially treated for an iliac aneurysm with the afx abdominal aortic aneurysm (aaa) stent; this is an off-label initial implant as afx is intended for aaa treatment.Approximately four and a half years post initial procedure, the patient presented with type ia and ii endoleaks as detected per ct (computed tomography) at routine follow-up.The physician plans to re-intervene and surgery is scheduled for (b)(6) 2020.As of date, there have been no additional patient sequelae reported.Additional information: the physician performed a secondary endovascular procedure on (b)(6) 2020, with an afx bifurcated stent graft and vela suprarenal.The final patient status was not reported.
|
| |
|
Search Alerts/Recalls
|